Institution · Aeterna Zentaris (Germany)

Most cited papers from Aeterna Zentaris (Germany)

Aeterna Zentaris (Germany)

What are the most cited papers from Aeterna Zentaris (Germany)?

The most cited paper from Aeterna Zentaris (Germany) is "Oral Miltefosine for Indian Visceral Leishmaniasis" (Shyam Sundar, T. K. Jha, C.P. Thakur et al., 2002), with 782 citations. Next come "Requirement of central ghrelin signaling for alcohol reward" (428) and "Miltefosine for New World Cutaneous Leishmaniasis" (384).

Published TypeFieldAccessCitations

Showing 50 of 60 papers. Every paper with more than 13 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Oral Miltefosine for Indian Visceral Leishmaniasis Shyam Sundar, T. K. Jha, C.P. Thakur et al. · New England Journal of Medicine Open access	28 Nov 2002	782
2	Requirement of central ghrelin signaling for alcohol reward Elisabet Jerlhag, Emil Egecioglu, Sara Landgren et al. · Proceedings of the National Academy of Sciences Open access	29 Jun 2009	428
3	Miltefosine for New World Cutaneous Leishmaniasis Jaime Soto, Byron A. Arana, Julia T Toledo et al. · Clinical Infectious Diseases	20 Apr 2004	384
4	Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease Annette E. Maczurek, Klaus Heinz Hager, Marlene Kenklies et al. · Advanced Drug Delivery Reviews ReviewOpen access	7 Jul 2008	347
5	PRECLINICAL STUDY: FULL ARTICLE: Ghrelin increases intake of rewarding food in rodents Emil Egecioglu, Elisabet Jerlhag, Nicolas Salomé et al. · Addiction Biology Open access	6 May 2010	331
6	Lipoic acid as a novel treatment for Alzheimer's disease and related dementias Lina Holmquist, Grant Stuchbury, Katrin Berbaum et al. · Pharmacology & Therapeutics	21 Sep 2006	290
7	Phase 4 Trial of Miltefosine for the Treatment of Indian Visceral Leishmaniasis Sujit Bhattacharya, Prabhat Kumar Sinha, Shyam Sundar et al. · The Journal of Infectious Diseases	25 Jul 2007	261
8	Development of miltefosine as an oral treatment for leishmaniasis HERBERT SINDERMANN, Jörgen Engel · Transactions of the Royal Society of Tropical Medicine and Hygiene	27 May 2006	188
9	Miltefosine – discovery of the antileishmanial activity of phospholipid derivatives Simon L. Croft, Juergen Engel · Transactions of the Royal Society of Tropical Medicine and Hygiene	15 Aug 2006	181
10	α-Lipoic acid as a new treatment option for Alzheimer’s disease — a 48 months follow-up analysis Klaus Heinz Hager, Marlene Kenklies, Jordan McAfoose et al. Book chapter	2007	156
11	Efficacy and Tolerability of Miltefosine for Childhood Visceral Leishmaniasis in India Sujit Bhattacharya, T. K. Jha, Shyam Sundar et al. · Clinical Infectious Diseases Open access	6 Jan 2004	148
12	A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells Arnold H. van der Luit, Stefan R. Vink, Jeffrey B. Klarenbeek et al. · Molecular Cancer Therapeutics Open access	Aug 2007	139
13	Treatment of Bolivian Mucosal Leishmaniasis with Miltefosine Jaime Soto, Julia T Toledo, Luis Valda et al. · Clinical Infectious Diseases	17 Jan 2007	136
14	Macimorelin as a Diagnostic Test for Adult GH Deficiency José M. Garcia, Beverly M. K. Biller, Márta Korbonits et al. · The Journal of Clinical Endocrinology & Metabolism Open access	31 May 2018	116
15	Oral Miltefosine for Leishmaniasis in Immunocompromised Patients: Compassionate Use in 39 Patients with HIV Infection HERBERT SINDERMANN, Kirsten Engel, Christina M. Fischer et al. · Clinical Infectious Diseases Open access	2 Nov 2004	113
16	Lung deposition of inhaled α 1 -proteinase inhibitor in cystic fibrosis and α 1 -antitrypsin deficiency Peter Brand, Marcia C. Schulte, Marion Wencker et al. · European Respiratory Journal Open access	27 Feb 2009	112
17	Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis Shyam Sundar, T. K. Jha, HERBERT SINDERMANN et al. · The Pediatric Infectious Disease Journal	May 2003	89
18	Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer Daniela Massihnia, Amir Avan, Niccola Funel et al. · Journal of Hematology & Oncology Open access	6 Jan 2017	87
19	Miltefosine (Impavido): the first oral treatment against leishmaniasis HERBERT SINDERMANN, Simon L. Croft, Kirsten Engel et al. · Medical Microbiology and Immunology	26 Sep 2003	86
20	Evariquinone, isoemericellin, and stromemycin from a sponge derived strain of the fungus Emericella variecolor Gerhard Bringmann, Gerhard Klaus Lang, S. Steffens et al. · Phytochemistry	28 May 2003	80
21	New Findings in PiZZ α1-Antitrypsin Deficiency-Related Panniculitis Bettina Gross, Markus Grebe, Marion Wencker et al. · Dermatology Open access	2009	75
22	Anorexigenic and electrophysiological actions of novel ghrelin receptor (GHS-R1A) antagonists in rats Nicolas Salomé, David Haage, Daniel Perrissoud et al. · European Journal of Pharmacology	6 Apr 2009	73
23	Phase I and pharmacokinetic study of combined treatment with perifosine and radiation in patients with advanced solid tumours Stefan R. Vink, Jan H.M. Schellens, Jos H. Beijnen et al. · Radiotherapy and Oncology	Aug 2006	72
24	Paclitaxel Encapsulated in Cationic Liposomes Increases Tumor Microvessel Leakiness and Improves Therapeutic Efficacy in Combination with Cisplatin Sebastian Strieth, Martin Eichhorn, Alexander Werner et al. · Clinical Cancer Research	15 Jul 2008	65
25	N-Benzoylated Phenoxazines and Phenothiazines: Synthesis, Antiproliferative Activity, and Inhibition of Tubulin Polymerization Helge Prinz, Behfar Chamasmani, Kirsten Vogel et al. · Journal of Medicinal Chemistry Open access	12 May 2011	64
26	GnRH-II Antagonists Induce Apoptosis in Human Endometrial, Ovarian, and Breast Cancer Cells via Activation of Stress-Induced MAPKs p38 and JNK and Proapoptotic Protein Bax S Fister, Andreas R. Günthert, Babette Aicher et al. · Cancer Research Open access	Aug 2009	63
27	Dose escalation and pharmacokinetic study of AEZS-108 (AN-152), an LHRH agonist linked to doxorubicin, in women with LHRH receptor-positive tumors Günter Emons, Manfred Kaufmann, G Gorchev et al. · Gynecologic Oncology Open access	13 Sep 2010	60
28	Tumor‐selective vessel occlusions by platelets after vascular targeting chemotherapy using paclitaxel encapsulated in cationic liposomes Sebastian Strieth, Claudia Nußbaum, Martin Eichhorn et al. · International Journal of Cancer	4 Oct 2007	57
29	Efficacy and safety of AEZS-108 (INN: Zoptarelin Doxorubicin Acetate) an LHRH agonist linked to doxorubicin in women with platinum refractory or resistant ovarian cancer expressing LHRH receptors: A multicenter Phase II trial of the ago-study group (AGO GYN 5) Günter Emons, G Gorchev, Jalid Sehouli et al. · Gynecologic Oncology	5 Apr 2014	54
30	Sulfonate Derivatives of Naphtho[2,3-b]thiophen-4(9H)-one and 9(10H)-Anthracenone as Highly Active Antimicrotubule Agents. Synthesis, Antiproliferative Activity, and Inhibition of Tubulin Polymerization Anne Zuse, Peter M. Schmidt, Silke Baasner et al. · Journal of Medicinal Chemistry Open access	31 Oct 2007	50
31	On the Central Mechanism Underlying Ghrelin’s Chronic Pro‐Obesity Effects in Rats: New Insights from Studies Exploiting a Potent Ghrelin Receptor Antagonist Nuno Salomé, Caroline Hansson, Magdalena Taube et al. · Journal of Neuroendocrinology Open access	20 Aug 2009	47
32	Antagonist and agonist binding models of the human gonadotropin-releasing hormone receptor J. Arvid Söderhäll, Emmanuel E. Polymeropoulos, Klaus Paulini et al. · Biochemical and Biophysical Research Communications	10 Jun 2005	46
33	Luteinizing Hormone-Releasing Hormone Receptor-Targeted Chemotherapy Using AN-152 Günter Emons, HERBERT SINDERMANN, Jürgen Engel et al. · Neuroendocrinology Open access	2009	46
34	Miltefosine: issues to be addressed in the future Jonathan Berman, Anthony D.M. Bryceson, Simon L. Croft et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene	6 Jun 2006	42
35	First-time-in-man and pharmacokinetic study of weekly oral perifosine in patients with solid tumours Clemens Unger, Wolfgang E. Berdel, Axel‐R. Hanauske et al. · European Journal of Cancer	15 Jan 2010	38
36	Adsorption of the decapeptide Cetrorelix depends both on the composition of dissolution medium and the type of solid surface Holger Grohganz, Matthias Rischer, Martin Brandl · European Journal of Pharmaceutical Sciences	12 Dec 2003	37
37	Cationic lipid complexed camptothecin (EndoTAG®-2) improves antitumoral efficacy by tumor vascular targeting Martin Eichhorn, Siiri Luedemann, Sebastian Strieth et al. · Cancer Biology & Therapy Open access	Jun 2007	37
38	Current View on the Mechanism of Action of Perifosine in Cancer Joachim Fensterle, Babette Aicher, Irene Seipelt et al. · Anti-Cancer Agents in Medicinal Chemistry	Apr 2014	36
39	NMR Solution Structure and Dynamics of the Peptidyl-prolyl cis–trans Isomerase Domain of the Trigger Factor from Mycoplasma genitalium Compared to FK506-binding Protein Martin Vogtherr, Doris M. Jacobs, Tatjana N. Parac‐Vogt et al. · Journal of Molecular Biology	May 2002	35
40	Sensitivity and specificity of the macimorelin test for diagnosis of AGHD José M. Garcia, Beverly M. K. Biller, Márta Korbonits et al. · Endocrine Connections Open access	15 Dec 2020	34
41	Clinical performance of the novel DiaSorin LIAISON® XL murex: HBsAg Quant, HCV-Ab, HIV-Ab/Ag assays Adalbert Krawczyk, Christian Hintze, J R Ackermann et al. · Journal of Clinical Virology	7 Nov 2013	26
42	A physiologically based pharmacokinetic (PBPK) parent-metabolite model of the chemotherapeutic zoptarelin doxorubicin—integration of in vitro results, Phase I and Phase II data and model application for drug–drug interaction potential analysis Nina Hanke, Michael Teifel, Daniel Moj et al. · Cancer Chemotherapy and Pharmacology	4 Dec 2017	24
43	Synthesis, antiproliferative activity and inhibition of tubulin polymerization by 1,5- and 1,8-disubstituted 10H-anthracen-9-ones bearing a 10-benzylidene or 10-(2-oxo-2-phenylethylidene) moiety Holger C. Nickel, Peter M. Schmidt, Konrad Joachim Böhm et al. · European Journal of Medicinal Chemistry Open access	3 May 2010	23
44	Development status of miltefosine as first oral drug in visceral and cutaneous leishmaniasis Christina M. Fischer, A. Voss, Jörg Bernhard Engel · Medical Microbiology and Immunology	24 Aug 2001	23
45	Synthesis and biological evaluation of novel cytotoxic azanaphthoquinone annelated pyrrolo oximes Karem Shanab, Nipawan Pongprom, Eva Wulz et al. · Bioorganic & Medicinal Chemistry Letters	19 Sep 2007	22
46	Nanofibers Resulting from Cooperative Electrostatic and Hydrophobic Interactions between Peptides and Polyelectrolytes of Opposite Charge Matthias Ferstl, Andrea Straßer, Hans‐Joachim Wittmann et al. · Langmuir	17 Oct 2011	21
47	Development and validation of a HPLC method for routine quantification of the decapeptide Cetrorelix in liposome dispersions Holger Grohganz, Oliver Schläfli, Matthias Rischer et al. · Journal of Pharmaceutical and Biomedical Analysis	27 Jan 2004	21
48	Modeling and Finite Element Formulation for Acoustic Problems Including Rotating Domains Manfred Kaltenbacher, Andreas Hüppe, Jens Grabinger et al. · AIAA Journal	15 Jul 2016	20
49	Synthesis and structure–activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents Pascal Marchand, Maud Antoine, Guillaume Le Baut et al. · Bioorganic & Medicinal Chemistry	26 Jul 2009	20
50	Fibermalt is well tolerated in healthy men and women at intakes up to 60 g/d: a randomized, double-blind, crossover trial Kevin Carl Maki, Tia M. Rains, Kathleen Kelley et al. · International Journal of Food Sciences and Nutrition	30 Oct 2012	19

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.